| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $247,993,385 ) (Continued on the next page) |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R00AG068425 | Real-time manipulations to understand and improve memory processes | 000 | 5 | NIH | 1/30/2025 | $224,100 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM151179 | Determinants of epigenetic inheritance in human stem cell fate decisions | 000 | 3 | NIH | 6/18/2025 | $441,250 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01GM152641 | The mechanism of extra-visual circadian photoentrainment in mammals | 000 | 2 | NIH | 12/16/2024 | $368,743 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01MH135730 | Scaling up integrated PrEP delivery in Kenyan maternal and child health clinics for pregnant and postpartum women | 000 | 2 | NIH | 11/1/2024 | $533,517 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01NS115747 | Identifying new targets in pain, utilizing the novel analgesic AS1 | 000 | 5 | NIH | 12/5/2024 | $336,644 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UG3CA290286 | Self-Testing for Cervical Cancer in Priority Populations: the STEP-2 Trial | 001 | 2 | NIH | 5/22/2025 | $65,192 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UG3CA290286 | Self-Testing for Cervical Cancer in Priority Populations: the STEP-2 Trial | 000 | 2 | NIH | 4/8/2025 | $586,737 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01NS131810 | Integrative circuit dissection in the behaving nonhuman primate | 001 | 3 | NIH | 5/12/2025 | $910,937 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01NS131810 | Integrative circuit dissection in the behaving nonhuman primate | 002 | 3 | NIH | 5/30/2025 | $0 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K08GM153069 | Intelligent wearable system for preventing medication errors in anesthesiology | 000 | 2 | NIH | 5/1/2025 | $187,383 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K08GM153069 | Intelligent wearable system for preventing medication errors in anesthesiology | 000 | 2 | NIH | 5/1/2025 | $23,100 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U24DA058307 | HIV and Substance Use Cohort Coordinating Center for Emerging and High Impact Scientific Cross Cohort Studies: HIV SUCCESS | 000 | 3 | NIH | 4/24/2025 | $929,341 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K25DK132416 | Noninvasive Repositioning of Kidney Stone Fragments with Acoustic Forceps | 000 | 3 | NIH | 11/29/2024 | $191,239 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21AG089394 | Illuminating early microglial dysfunction in Alzheimer's disease through integration of explainable AI and iPSC models | 000 | 2 | NIH | 5/13/2025 | $230,642 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R00HD105203 | Mechanisms of Skeletal Morphogenesis During Digit Tip Regeneration | 000 | 4 | NIH | 2/13/2025 | $224,100 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21AI182705 | Discovery of fungus-derived natural products as new and effective Antigiardial agents. | 000 | 2 | NIH | 2/28/2025 | $200,086 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K08HL166696 | Hemodynamic Contributions to Vascular Dysfunction in Pulmonary Arterial Hypertension | 000 | 3 | NIH | 2/28/2025 | $187,056 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI080609 | Mechanisms for sensing and responding to interbacterial antagonism | 000 | 15 | NIH | 3/19/2025 | $505,792 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K23AR079588 | Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer | 001 | 4 | NIH | 6/26/2025 | $163,014 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K23AR079588 | Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer | 000 | 3 | NIH | 2/27/2025 | $2,000 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21CA300956 | Epigenetics, accelerated aging, and cardiovascular health during breast cancer treatment | 000 | 1 | NIH | 3/17/2025 | $279,411 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI162684 | Role of IRE1 Alpha in Coronavirus Infections | 000 | 4 | NIH | 2/13/2025 | $557,476 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AG087226 | Amyloid Beta and Collagen IV Interactions in the Brain Microvasculature in Alzheimers Disease | 001 | 2 | NIH | 6/10/2025 | $54,797 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AG087226 | Amyloid Beta and Collagen IV Interactions in the Brain Microvasculature in Alzheimers Disease | 000 | 2 | NIH | 3/17/2025 | $616,458 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | D43TW011817 | Tuberculosis & HIV Co-Infection Training Program in Kenya | 000 | 5 | NIH | 3/10/2025 | $236,554 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | D43TW011817 | Tuberculosis & HIV Co-Infection Training Program in Kenya | 000 | 5 | NIH | 3/10/2025 | $50,000 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R00ES031050 | A systematic study of the environmental etiology of autism spectrum disorder using high-throughput behavioral screening | 002 | 5 | NIH | 5/20/2025 | $0 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R00ES031050 | A systematic study of the environmental etiology of autism spectrum disorder using high-throughput behavioral screening | 001 | 5 | NIH | 3/21/2025 | $249,000 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R00ES031050 | A systematic study of the environmental etiology of autism spectrum disorder using high-throughput behavioral screening | 000 | 4 | NIH | 3/12/2025 | $123,784 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI183692 | Molecular determinants and functions of bacterial polysaccharide cellular localization | 000 | 1 | NIH | 2/25/2025 | $783,557 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31CA301530 | Elucidating the role of type 2 conventional dendritic cells in shaping anti-tumor immunity | 000 | 1 | NIH | 6/25/2025 | $49,538 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UH3OD035528 | ECHO Yakima Valley | 000 | 3 | NIH | 6/6/2025 | $1,991,102 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI174304 | In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cure | 000 | 3 | NIH | 2/12/2025 | $1,399,750 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI167923 | Regulation of the tuft-ILC2 circuit in the small intestine | 000 | 4 | NIH | 2/13/2025 | $540,973 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21AI188716 | Single-cell transcriptional atlas of Giardia encystation | 000 | 1 | NIH | 2/24/2025 | $218,767 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R38AI181011 | Reproductive and Child Health StaRR Program | 000 | 1 | NIH | 3/1/2025 | $402,731 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R03AI188419 | Defining the larval repertoire of Aedes aegypti somatosensory neurons | 000 | 1 | NIH | 2/28/2025 | $75,418 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AG071024 | Short and long-term consequences of wildfires for Alzheimer's disease and related dementias | 001 | 4 | NIH | 6/17/2025 | $49,119 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01EY035647 | Noncontact in vivo guidance of corneal collagen crosslinking therapy with optical coherence tomography and acoustic micro-tapping elastography | 000 | 2 | NIH | 2/14/2025 | $608,808 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AG071024 | Short and long-term consequences of wildfires for Alzheimer's disease and related dementias | 000 | 4 | NIH | 3/11/2025 | $552,587 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HD101422 | Repurposing Azithromycin for premature brain injury | 001 | 5 | NIH | 4/15/2025 | $48,081 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HD101422 | Repurposing Azithromycin for premature brain injury | 000 | 5 | NIH | 2/14/2025 | $432,741 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01MH135901 | Developing Data-Driven Clinical Signatures for People Who Experience Hallucinations | 000 | 2 | NIH | 3/11/2025 | $2,139,265 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HG010632 | Versatile, exponentially scalable methods for single cell molecular profiling | 002 | 6 | NIH | 6/5/2025 | $655,233 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1AI148573 | University of Washington Vaccine and Treatment Evaluation Unit | 000 | 6 | NIH | 3/4/2025 | $621,600 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1AI148573 | University of Washington Vaccine and Treatment Evaluation Unit | 000 | 6 | NIH | 3/4/2025 | $1,906,189 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | T90DE021984 | Comprehensive Training in Inter-Disciplinary Oral Health Research | 002 | 14 | NIH | 6/26/2025 | $650,985 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21AI182722 | An Intestinal Helminth Promotes Enteric Viral Infection Independent of Type 2 Immunity | 000 | 2 | NIH | 3/19/2025 | $214,006 |
| 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R34MH131571 | IMAGINE: pilot trial of a digital group intervention to prevent perinatal depression | 000 | 2 | NIH | 2/19/2025 | $259,659 |
|